NEW YORK, Jan 26 - A trial to determine whether a patent Amersham Pharmacia Biotech holds for DNA chemistries is valid and enforceable has been delayed from January 29 until March, AP Biotech said Friday.

The judge in the jury trial, which stems from a lawsuit AP Biotech brought against Applied Biosystems and its sister company Celera, will use the extra time to decide whether the patent issue also includes Applied Biosystems’ soon-to-be-released Version 3 of  its “Big Dye” products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more